Details of the Drug
General Information of Drug (ID: DMOQ43W)
| Drug Name |
Naphthalene-1,4-diol
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Naphthalene-1,4-diol; 1,4-Dihydroxynaphthalene; 571-60-8; 1,4-NAPHTHALENEDIOL; 1,4-Naphthohydroquinone; Hydronaphthoquinone; Naphthohydroquinone; 1,4-Naphthoquinol; alpha-Naphthoquinhydrone; UNII-AML1P6T42C; CCRIS 7897; Naphthalene-1,4-dio; alpha-Naphthohydroquinone; EINECS 209-336-4; BRN 1307689; AML1P6T42C; CHEMBL206816; CHEBI:34063; PCILLCXFKWDRMK-UHFFFAOYSA-N; 1,4-Naphththalenediol; 1-Hydroxy-4-naphthol; 1,4-Naphthalene diol; napthalene- 1,4-diol; ACMC-1AXHC; Naphthalenediol-(1,4); 1,4-Dihydroxy-naphthalene; AC1L1X2M
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 160.17 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 1.8 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


